Crossmark

Immunotherapy checkpoint inhibitor-combination therapy versus chemotherapy alone among Chinese population in cholangiocarcinoma treatment: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1007/s00228-025-03948-x

Published Online: 2026-01-17

Published Print: 2026-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shi, Li

Du, Wei

Miao, Juan

Peng, Xi-Yuan

Li, Wei

Ur-Rehman, Attiq

Ge, Meng-Wei

Shen, Lu-Ting

Feng, Rui

Zhong, Kang

Gao, Si-Qi

Chen, Hong-Lin
Funding

Funding for this research was provided by:

the Project of Social Science Foundation of Jiangsu Province (24SHB008)
License Information

Text and Data Mining valid from 2026-01-17

Version of Record valid from 2026-01-17
More Information

Article History

Received: 12 August 2025

Accepted: 21 October 2025

First Online: 17 January 2026

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below